NR3C1 and familial pancreatic carcinoma: However, it is unknown whether GR signaling in cancer cells exerts an immunosuppressive effect on the TME, and if so, whether this can be exploited to sensitize “cold” tumors such as pancreatic cancer to ICB therapy.